Modification of lipoproteins in uremia: Oxidation, glycation and carbamoylation

Mineral and Electrolyte Metabolism

Volumn 25, Issue 4-6, 1999, Pages 263-268

  Galle, Jan ^b   Wanner, Christoph ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b NONE

Author keywords

Atherosclerosis; Free radicals; Glomerulosclerosis; Glycation; Oxidative stress; Oxidized LDL; Superoxide anion; Uremia

Indexed keywords

ADVANCED GLYCATION END PRODUCT; APOLIPOPROTEIN B100; CYANIC ACID; LIPID PEROXIDE; LIPOPROTEIN; LIPOPROTEIN A; OXIDIZED LOW DENSITY LIPOPROTEIN; UREA;

ATHEROSCLEROSIS; CONFERENCE PAPER; GLOMERULOSCLEROSIS; HUMAN; KIDNEY FAILURE; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; UREMIA;

EID: 0033370121     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057458     Document Type: Conference Paper

References (72)

1. Dahlen GH: Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 1994;108:111-126.
2. Kronenberg F, Steinmetz A, Kostner GM, Dieplinger H: Lipoprotein(a) in health and disease. Crit Rev Clin Lab Sci 1996;33:495-543.
3. Scandinavian Simvastatin Survival Studygroup: The Scandinavian simvastatin survival study (4S). Lancet 1994;244:1383-1389.
4. Palinski W, Rosenfeld ME, Yla ̈-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witzum JL: Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989; 86:1372-1376.
5. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.
6. Numano F, Tanaka A, Makita T, Kishi Y: Glycated lipoprotein and atherosclerosis. Ann NY Acad Sciences 1997;811:100-114.
7. Lyons TJ: Glycation and oxidation: A role in the pathogenesis of atherosclerosis. Am J Cardiol 1993;71:268-318.
8. Hörkkö S, Huttunen K, Kervinen K, Kesaniemi YA: Decreased clearance of uraemic and mildly carbamylated low-density lipoprotein. Eur J Clin Invest 1994;24:105-113.
9. Gröne EF, Walli AK, Gröne H-J, Miller B, Seidel D: The role of lipids in nephrosclerosis and glomerulosclerosis. Atherosclerosis 1994;107:1-13.
10. Magil AB, Frohlich JJ, Innis SM, Steinbrecher UP: Oxidized low-density lipoprotein in experimental focal glomerulosclerosis. Kidney Int 1993;43:1243-1250.
11. Steinbrecher U, Parthasarathy S, Leake D, Witzum J, Steinberg D: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984;81:3883-3887.
12. Esterbauer H, Quehenberger O, Jürgens G: Oxidation of human low density lipoprotein with special attention to aldehydic lipid peroxidation products; in Rice-Evans C. Halliwell B (eds): Free Radicals Methodology and Concepts. London, Richelieu Press, 1988, pp 243-267.
13. Berliner JA, Heinecke JW: The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996;20:707-727.
14. Holvoet P, Collen D: Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. Atherosclerosis 1998;137:833-538.
15. Ylä-Herttuala S: Is oxidized low-density lipoprotein present in vivo? Curr Opin Lipidol 1998; 9:337-344.
16. Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U: Detection and quantification of lipoprotein(A) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 1989;9:579-592.
17. Sato H, Suzuki S, Ueno M, Shimada H, Karasawa R, Nishi S-I, Arakawa M: Localization of apolipoprotein(a) and B-100 in various renal diseases. Kidney Int 1993;43:430-435.
18. Ichikawa I, Kiyama S, Yoshioka T: Renal antioxidant enzymes: Their regulation and function. Kidney Int 1994;45:1-9.
19. Witko Sarsat V, Friedlander M, Capeillere Blandin C, Nguyen Khoa T, Nguyen AT, Zingraff J. Jungers P, Descamps Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49:1304-1313.
20. Ceballos Picot I, Witko Sarsat V, Merad Boudia M, Nguyen AT, Thevenin M, Jaudon MC, Zingraff J, Verger C, Jungers P, Descamps Latscha B: Glutathione antioxidant system as a marker of oxidativc stress in chronic renal failure. Free Radic Biol Med 1996;21:845-853.
21. Roselaar SE, Nazhat NB, Winyard PG, Jones P, Cunningham J, Blake DR: Detection of oxidants in uremic plasma by electron spin resonance spectroscopy. Kidney Int 1995;48: 199-206.
22. Epperlein MM, Nourooz-Zadeh J, Jayasena SD, Hothersall JS, Noronha-Dutra A, Neild GH: Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol 1998;9:457-463.
23. Martgin Mateo MC, del Canto Jafiez E, Barrero Martinez MJ: Oxidative stress and enzyme activity in ambulatory renal patients undergoing continuous peritoneal dialysis. Ren Fail 1998; 20:117-124.
24. McGrath LT, Douglas AF, McClean E, Brown JH, Doherty CC, Johnson GD, Archbold GP: Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular dialysis. Clin Chim Acta 1995;235:179-188.
25. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenane hemodialysis. N Engl J Med 1974; 290:697-701.
26. London GM, Drüeke TB: Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997;51:1678-1695.
27. Lee HS, Jeong JY, Kim BC, Kim YS, Zhang YZ, Chung HK: Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis. Kidney Int 1997;51:1151-1159.
28. Lee HS, Kim YS: Identification of oxidized low density lipoprotein in human renal biopsies. Kidney Int 1998;54:848-856.
29. Maggi E, Bellazzi R, Falaschi F, Frattoni A, Perani G, Finardi G, Gazo A, Nai M, Romanini D, Bellomo G: Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis. Kidney Int 1994;45: 876-883.
30. Holvoet P, Donck J, Landeloos M, Brouwers E, Luijtens K, Arnout J, Lesaffre E, Vanrenterghem Y, Collen D: Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemostas 1996;76:663-669.
31. Itabe H, Yamamoto H, Imanaka T, Shimamura K, Uchiyama H, Kimura J, Sanaka T, Hata Y, Takano T: Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res 1996;37:45-53.
32. Odetti P, Garibaldi S, Gurrwri G, Aragno I, Dapino D, Pronzato MA, Marinari UM: Protein oxidation in hemodialysis and kidney transplantation. Metabolism 1996;45:1319-1322.
33. Canestrari F, Buoneristiani U, Galli F, Giorgini A, Albertini MC, Carobi C, Pascucci M, Bossu M: Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients. Clin Chim Acta 1995;234:127-136.
34. Haklar G, Yegenaga I, Yalcin AS: Evaluation of oxidant stress in chronic hemodialysis patients: Use of different parameters. Clin Chim Acta 1995;234:109-114.
35. Panzetta O, Cominacini L, Garbin U, Pasini AF, Gammaro L, Bianco F, Davoli A, Campagnola M, De Santis A, Pastorino AM, Lo Cascio V: Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis. Effects offish oil and vitamin E administration. Clin Nephrol 1995;44:303-309.
36. Maggi E, Bellazzi R, Gazo A, Seccia M, Bellomo G: Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int 1994;46:869-876.
37. Toborek M, Wasik T, Drózdz M, Klin M, Magner-Wròbel K, Kopieczna-Grzebieniak E: Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 1992;41:1229-1232.
38. Westhuyzen J, Saltissi D, Healy H: Oxidation of low density lipoprotein in hemodialysis patients: Effect of dialysis and comparison with matched controls. Atherosclerosis 1997;129:199-205.
39. Loughrey CM, Young IS, McEneny J, McDowell IFW, McMaster C, McNamee PT, Trimble ER: Oxidation of low density lipoprotein in patients on regular haemodialysis. Atherosclerosis 1994;110:185-193.
40. Sutherland WHF, Walker RJ, Ball MJ, Stapley SA, Robertson MC: Oxidation of low density lipoproteins from patients with renal failure or renal transplants. Kidney Int 1995;48:227-236.
41. Schulz T, Schiffl H, Scheithe R, Hrboticky N, Lorenz R: Preserved antioxidative defense of lipoproteins in renal failure and during hemodialysis. Am J Kidney Dis 1995;25:564-571.
42. Schettler V, Wieland E, Verwiebe R, Schuff-Weiner F, Scheler F, Cellerich M: Plasma lipids are not oxidized during hemodialysis. Nephron 1994;67:42-47.
43. Taus M, Ferretti G, Curatola G, Dousset N, Solèra ML, Valdiguie P: Lower susceptibility of low density lipoprotein to in vitro oxidation in diabetic patients. Biochem Int 1992;28:835-842.
44. Mazière C, Auclair M, Rose-Robert F, Leflon P, Mazière JC: Glucose-enriched medium enhances cell-mediated low density lipoprotein peroxidation. FEBS Lett 1995;363:277-279.
45. Kawamura M, Heinecke JW, Chait A: Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest 1994;94:771-778.
46. Bowie A, Owens D, Collins P, Johnson A, Tomkin GH: Glycosylated low density lipoprotein is more sensitive to oxidation: Implications for the diabetic patient. Atherosclerosis 1993; 102:63-67.
47. Graier WF, Kostner GM: Cheated low-density lipoprotein and atherogenesis: The missing link between diabetes mellitus and hypercholesterolaemia? Eur J Clin Invest 1997;27:457-459.
48. Bucala R, Vlassara H: Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis 1995;26:875-888.
49. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C: Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997;51:1170-1181.
50. Fishbane S, Bucala R, Pereira BJG, Founds H, Vlassara H: Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremia. Kidney Int 1997;52:1645-1650.
51. Mitsuhashi T, Li YM, Fishbane S, Vlassara H: Depletion of reactive advanced glycation end-products from diabetic uremic sera using a lysozyme-linked matrix. J Clin Invest 1997;100: 847-854.
52. Miyata T, Maeda K, Kurokawa K, van Ypersele de Strihou C: Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial Transplant 1997;12:255-258.
53. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H: Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 1994;91:9441-9445.
54. Hörkkö S, Savolainen MJ, Kervinen K, Kesaniemi YA: Carbamylation-induced alterations in low-density lipoprotein metabolism. Kidney Int 1992;41:1175-1181.
55. Palinski W, Hörkkö S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL: Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice - Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 1996;98:800-814.
56. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasaralhy S, Carew TE, Butler S, Witzum JL, Steinberg D: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086-1095.
57. Esterbauer H, Jürgens G, Quchenberger O, Koller E: Autoxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 1987;28:495-509.
58. Galle J, Wanner C: Oxidized LDL and Lp(a) Preparation, modification, and analysis: in Armstrong D (ed): Free Radical and Antioxidant Protocols. Totowa, NJ, Humana Press, 1998. vol 12, pp 119-130.
59. Esterbauer H, Striegel G, Puhl H, Rotheneder M: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comm 1989;6:67-75.
60. Steinbrecher UP, Witztum JL, Parthasarathy S, Steinberg D: Decrease in reactive amino group during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis 1987; 7:135-143.
61. Makino K, Furbee JW Jr, Seanu AM, Fless GM: Effect of glycation on the properties of lipoprotein(a). Arterioscler Thromb 1995;15: 385-391.
62. Bucala R: Lipoprotein modification by advanced glycosylation endproducts (AGEs): Role in atherosclerosis. Trends Cardiovasc Med 1997; 7:39-47.
63. Doucet C, Huby T, Ruiz J, Chapman MJ, Thillet J: Non-enzymatic glycation of lipoprotein(a) in vitro and in vivo. Atherosclerosis 1995;118:135-143.
64. Münch G, Keis R, Wessels A, Riederer P, Bahner U, Heidland A, Niwa T, Lemke H, Schinzel R: Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 1997;35:669-677.
65. Habeeb A: Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 1966;14:328-336.
66. Kraus LM, Miyamura S, Pecha BR, Kraus AP, Jr: Carbamoylation of hemoglobin in uremic patients determined by antibody specific for homocitrulline (carbamoylated epsilon-N-lysine). Mol Immunol 1991;28:459-463.
67. Goldstein JE, Basu HJK, Brown MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979;76:333-337.
68. Galle J, Bengen J, Schollmeyer P, Wanner C: Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a) - Role of oxygen-derived radicals. Circulation 1995;92:1582-1589.
69. 2 and renin release in juxtaglomerular cells. Kidney Int 1997;51:253-260.
70. Dimmeler S, Haendeler J, Galle J, Zeiher AM: Oxidized low density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: A mechanistic clue to the 'response to injury' hypothesis. Circulation 1997;95:1760-1763.
71. Galle J, Schneider R, Heinloth A, Wanner C, Galle PR, Conzelmann E, Dimmeler S, Hecrmeier K: Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: Role of oxidative stress. Kidney Int 1999;55(4): 1450-1461.
72. Galle J, Schneider R, Winner B, Lehmann-Bodem C, Schinzel R, Münch G, Conzelmann E, Wanner C: Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: Role of enhanced oxidative stress. Atherosclerosis 1998;138:65-77.